An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT-SOLO)
Condition: Rheumatoid ArthritisIntervention: Sponsor: Hoffmann-La RocheCompleted - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actemra | Arthritis | Research | Rheumatoid Arthritis | Rheumatology | Solo Practices | Study